Form 4: CalciMedica Director Eric Bjerkhult Granted Stock Options
SEC Form 4 Filing
Director Eric Bjerkhult received stock options for 10,000 shares of CalciMedica, Inc. at an exercise price of $4.16 on March 28, 2024.
Summary
- Eric Bjerkhult, a director of CalciMedica, Inc., was granted stock options on March 28, 2024.
- The options are for 10,000 shares of common stock.
- The exercise price of the options is $4.16 per share.
- The options vest in equal monthly installments over a one-year period following the grant date.
- The options expire on March 27, 2034.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock option grants, which is neutral in sentiment.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
Industry Context
Stock options are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders by incentivizing them to increase the company's stock value.
Stakeholder Impact
- The stock option grant could potentially incentivize the director to improve company performance, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of the stock option grant |
| 03/27/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.